Phase II study of CNM-Au8 in patients with relapsing remitting multiple sclerosis.
Phase of Trial: Phase II
Latest Information Update: 06 Feb 2018
At a glance
- Drugs CNM Au8 (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 06 Feb 2018 New trial record
- 02 Feb 2018 According to the Clene Nanomedicine media release, this trial is set to begin in the second half of 2018.